Skip to main content

Call for papers - HIV and TB co-infection

Guest Editors

Francesco Di Gennaro, MD, University of Bari Aldo Moro, Italy
Harriet Mayanja-Kizza, PhD, Makerere University, Uganda

Peter Nyasulu, PhD, Stellenbosch University, South Africa
Sheela Shenoi, MD, Yale School of Medicine, USA

Submission Status: Open   |   Submission Deadline: 20 December 2024

BMC Infectious Diseases is calling for submissions to our Collection on HIV and TB co-infection. This collection seeks to explore the complex relationship between tuberculosis (TB) and human immunodeficiency virus (HIV), two prominent pathogens within the domain of infectious diseases. We invite submissions on co-infection research, interventions, and perspectives from various stakeholders aiming to advance understanding and improve outcomes in the prevention, diagnosis, treatment, and control of HIV and TB co-infection, covering topics such as epidemiology, pathogenesis, clinical management, drug interactions, public health approaches, socioeconomic determinants, therapeutics innovation, community engagement, and health systems strengthening.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Meet the Guest Editors

Back to top

Francesco Di Gennaro, MD, University of Bari Aldo Moro, Italy

Dr Francesco Di Gennaro is an Associate Professor of Infectious and Tropical Diseases at the University of Bari Aldo Moro, where he also holds the position of research coordinator across various countries, including Ethiopia, Uganda, Mozambique, South Sudan, and Sierra Leone. Dr Di Gennaro's academic career is distinguished by numerous scientific publications, reflecting his research focus on Tuberculosis, HIV, vulnerable populations, migrant health, and antibiotic resistance. Additionally, he plays a vital role in global health initiatives as a member of the WHO Group of Joint External Evaluation (JEE), contributing his expertise to enhance global health security measures.

Harriet Mayanja-Kizza, PhD, Makerere University, Uganda

Dr Harriet Mayanja-Kizza is a distinguished figure in the medical field, renowned as a trainer and mentor for medical students and postgraduates, with a particular focus on the TB research. Her expertise focuses on TB, emphasis on immuno-pathogenesis, TB epidemiology and TB clinical trials. As the Co-Director of the esteemed Makerere-Yale global health program, now in its 18th year, she has played a pivotal role in shaping the program's success. Additionally, she holds the position of adjunct lecturer at Case Western Reserve University. Throughout her career, she has provided guidance and supervision to numerous Masters and Doctoral students, as well as researchers across various African countries including Uganda, Ethiopia, Rwanda, Namibia, and South Africa. Additionally, she contributes to the academic community as an Editorial Board Member at BMC Infectious Diseases, and her exceptional contributions have been recognized with the CUGH Global Health Distinguished Leadership Award in 2022.

Peter Nyasulu, PhD, Stellenbosch University, South Africa

Dr Peter Nyasulu is a Professor of Epidemiology at the Faculty of Medicine & Health Sciences, Stellenbosch University. His primary research focuses on infectious diseases and the health risks associated with climate change in low- to middle-income countries. He holds a PhD in Epidemiology and a Master of Science in Medicine specializing in Epidemiology and Biostatistics, both obtained from the School of Public Health at the University of Witwatersrand. Additionally, he holds a Postgraduate Diploma in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London, as well as an Advanced Diploma in Dermatovenereology from the University of Dar-es-Salaam and a Diploma in Clinical Medicine from the College of Health Sciences in Malawi. With extensive experience in Epidemiology and Public Health, Dr Nyasulu has made significant contributions to the field and has a substantial publication record.

Sheela Shenoi, MD, MPH, Yale School of Medicine, USA

Dr Sheela Shenoi is an Associate Professor of Medicine and Public Health in the AIDS Program of the Section of Infectious Diseases and Associate Director of the Office of Global Health at Yale University School of Medicine and School of Public Health. She evaluates strategies to improve TB and HIV diagnosis, linkage and retention in care, in prison settings and exploring the role of community-based services to facilitate implementation. She prioritizes prevention strategies and integration of HIV and TB services.

About the Collection

BMC Infectious Diseases is calling for submissions to our Collection on HIV and TB co-infection. 

This collection seeks to explore the complex relationship between tuberculosis (TB) and human immunodeficiency virus (HIV), two prominent pathogens within the domain of infectious diseases. 

HIV and TB co-infection presents a significant global health challenge, particularly in regions where both diseases are endemic. Mycobacterium tuberculosis, the causative agent of TB, and the human immunodeficiency virus (HIV), synergistically interact to amplify the burden and intricacy of each disease. This co-infection of two pathogens not only presents significant clinical obstacles but also necessitates comprehensive strategies for proficient control and mitigation.

This Collection welcomes submissions on co-infection research, innovative interventions, and insightful perspectives from clinicians, researchers, public health experts, and policymakers. By fostering collaboration and knowledge exchange, we aim to advance understanding and improve outcomes in the prevention, diagnosis, treatment, and control of HIV and TB co-infection. Key topics of interest include but are not limited to:

  • Epidemiology of HIV and TB co-infection, including trends, risk factors, and geographic disparities
  • Pathogenesis and immunological interactions between HIV and M. tuberculosis
  • Clinical applications, diagnosis, and management of HIV-associated TB and TB-associated HIV, including: detection of M. tuberculosis infection among persons with HIV infection, subclinical TB detection and management in HIV infection, extrapulmonary TB diagnosis and management in HIV infection
  • Drug-drug interactions and adverse events in dual HIV/TB treatment, strategies for integrated care and treatment optimization in co-infected individuals
  • Public health approaches for the prevention and control of HIV/TB co-infection, including screening, contact tracing, and vaccination
  • Socioeconomic determinants, health disparities, and challenges in addressing HIV/TB co-infection
  • Innovations in therapeutics, including drug development, regimen optimization, and pharmacovigilance
  • Community engagement, patient-centered care, and adherence support in HIV/TB co-infection management
  • Health systems strengthening, policy frameworks, and resource allocation for effective disease control and elimination


This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being
 

Image credit: Atlas / stock.adobe.com

  1. Up to now several studies estimate the prevalence of HBV, HCV, and TB among people living with HIV (PLWH) in Iran; however, their results are inconsistent. This study aimed to estimate the overall prevalence o...

    Authors: Ehsan Mostafavi, Bahram Ebrahimi, Amin Doosti-Irani and Ali Mirzazadeh
    Citation: BMC Infectious Diseases 2024 24:777
  2. Opportunistic infections (OIs) are common causes of mortality among people living with HIV (PLHIV). We determined prevalence and 30-day mortality due to histoplasmosis, cryptococcosis, and TB in PLHIV with adv...

    Authors: Gloria Aguilar, Gladys Lopez, Omar Sued, Narda Medina, Diego H. Caceres, Jose Pereira, Alexander Jordan, Virgilio Lezcano, Cristina Vicenti, Gustavo Benitez, Tania Samudio and Freddy Perez
    Citation: BMC Infectious Diseases 2024 24:406
  3. Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) co-morbidity continues to be a serious worldwide health issue, particularly in Sub-Saharan Africa. Studies on th...

    Authors: Jacob Nignan Nabei, Harriet Affran Bonful, Edwin Andrews Afari, Abdul Gafaru Mohammed and Adote Anum
    Citation: BMC Infectious Diseases 2024 24:396
  4. Non-sputum-based tests are needed to predict or diagnose tuberculosis (TB) disease in people living with HIV (PWH). The enzyme indoleamine 2, 3-dioxygenase-1 (IDO1) is expressed in tuberculoid granuloma and ca...

    Authors: Sivaporn Gatechompol, René Lutter, Frédéric M. Vaz, Sasiwimol Ubolyam, Anchalee Avihingsanon, Stephen J. Kerr, Frank van Leth and Frank Cobelens
    Citation: BMC Infectious Diseases 2024 24:372

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "HIV and TB co-infection" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.